A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Our Community Bookmark and Share

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
City of Hope Celebrates Hispanic Heritage Month
 
 
Here are some of the thoughts and feelings of our Latino employees. It couldn't be said any better:
"Not only does City of Hope support but encourages diversity."

"It's not just one size fits all, you can make it what you want it to be."

"I have a passion for learning… at City of Hope there are so many things to learn everyday."

"You're surrounded by the best minds this stimulates you to become the best scientist."

"You are part of an organization that impacts people daily, and we are changing lives, not only of the patient but of their entire family."

" ...everyone is there to do something amazing and support each other, it’s refreshing, extremely rare and absolutely unique."
 
Together, we are hope - #TogetherWeAreHope
 
Contact us at diversityandinclusion@coh.org for more information.

Our Community

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
City of Hope Celebrates Hispanic Heritage Month
 
 
Here are some of the thoughts and feelings of our Latino employees. It couldn't be said any better:
"Not only does City of Hope support but encourages diversity."

"It's not just one size fits all, you can make it what you want it to be."

"I have a passion for learning… at City of Hope there are so many things to learn everyday."

"You're surrounded by the best minds this stimulates you to become the best scientist."

"You are part of an organization that impacts people daily, and we are changing lives, not only of the patient but of their entire family."

" ...everyone is there to do something amazing and support each other, it’s refreshing, extremely rare and absolutely unique."
 
Together, we are hope - #TogetherWeAreHope
 
Contact us at diversityandinclusion@coh.org for more information.
We're a community of people characterized by our diversity of thought, background and approach.
 
We have career opportunities in nursing, research, allied health, business support and many other areas.
 
City of Hope employees enjoy excellent benefits and an environment that inspires wellness.
 
In addition to our main campus in Duarte, CA, we have several locations throughout the Los Angeles vicinity.
 
Current employees and external candidates are invited to explore our career opportunities.
 
City of Hope is a community of people characterized by our diversity of thought, background, and approach, but tied together by our commitment to care for and cure those with cancer and other life-threatening diseases. Download our Diversity & Inclusion brochure.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...
  • “Honestly, there’s nothing special about my story,” protested Daniel Samson, as he bounced Layla, his 3 1/2-year-old daughter, on his lap and put on a video for her to watch. “I just want to tell it for my own sake, and share it with other men who may be going through this chaos.” Samson spoke […]
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...
  • Sure, a healthy lifestyle can lower a person’s risk, but the impact of specific actions is harder to tease out. Diet, exercise, tobacco use, nutritional supplements, alcohol consumption … How important are each of these factors, individually? Does strict adherence to (or rejection of) one get you a pass o...
  • Health care decisions are tough. They’re even tougher when you – or loved ones – have to make them without a plan or a conversation. National Healthcare Decisions Day, on April 16,  is a nationwide initiative to demystify the health care decision-making process and encourage families to start talking. Ult...
  • The statistics, direct from the American Cancer Society, are sobering: Cancer death rates among African-American men are 27 percent higher than for white men. The death rate for African-American women is 11 percent higher compared to white women. Hispanics have higher rates of cervical, liver and stomach cancer...
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...